Global Kaposis Sarcoma Treatment Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 150.70 Billion |
 Market Size (Forecast Year) |
USD 258.93 Billion |
 CAGR |
% |
| Major Markets Players |
全球卡波西肉瘤治疗市场，按类型（流行性（艾滋病相关）卡波西肉瘤、经典（地中海）卡波西肉瘤、地方性（非洲）卡波西肉瘤、医源性（移植相关）卡波西肉瘤）、治疗（HAART、放射疗法、手术、冷冻手术、化疗、生物疗法）、最终用户（医院、家庭护理、专科中心、其他）、分销渠道（医院药房、网上药房、零售药房）划分 - 行业趋势和预测到 2030 年。
卡波西肉瘤治疗市场分析和规模
随着卡波西肉瘤发病率的上升和接受器官移植手术的患者数量的增加，接受器官移植的患者患上卡波西肉瘤的风险也随之增加。因艾滋病或器官移植手术后服用药物而导致免疫系统减弱的患者，极易感染 HHV-8。器官移植患者被要求服用免疫抑制剂，以防止身体对移植器官产生排斥，这增加了他们对卡波西肉瘤相关疱疹病毒 (KSHV) 感染的易感性。长期使用这些药物，这些患者的感染风险比普通人群高出 100 多倍。
Data Bridge Market Research 分析了 2023-2020 年预测期内全球卡波西肉瘤治疗市场的增长率。在上述预测期内，全球卡波西肉瘤治疗市场的预期复合年增长率约为 7.00%。2022 年市场价值为 1.507 亿美元，到 2030 年将增长至 2.5893 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。
市场定义
卡波西肉瘤是一种恶性肿瘤疾病，主要影响皮肤、粘膜、淋巴结和其他器官。这些斑块或病变通常呈红色或紫色。它们是由癌细胞、血管和血细胞组成的。人类疱疹病毒 8（HHV-8）主要存在于所有卡波西肉瘤患者的病变中。
卡波西肉瘤治疗市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021（可定制为 2015 - 2020） |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
Type (Epidemic (AIDS Associated) Kaposi Sarcoma, Classic (Mediterranean) Kaposi Sarcoma, Endemic (African) Kaposi Sarcoma, Latrogenic (Transplant-Related) Kaposi Sarcoma), Treatment (HAART, Radiation Therapy, Surgery, Cryosurgery, Chemotherapy, Biological Therapy), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
Johnson & Johnson Private Limited (U.S.), Abbott (U.S.), AbbVie Inc. (U.S.), Bausch Health Companies Inc. (Canada), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), Lupin (India), Hikma Pharmaceuticals PLC (U.K.), Amneal Pharmaceuticals LLC. (U.S.), Pfizer Inc (U.S.), Mylan N.V. (U.S.), Bristol-Myers Squibb Company (U.S.), GSK plc. (U.K.), Bayer AG (Germany) |
|
Market Opportunities |
|
Global Kaposi's Sarcoma Treatment Market Dynamics
Drivers
- Increased Transplantations
As per the records of the Global Observatory on Donation and Transplantation, 1 39,024 organs were transplanted worldwide in 2017 in total, which 90,306 (Kidney), 32,348 (Liver), 7,881 (Heart), 6,084 (Lung), 2,243 (Pancreas), 162 (Small Bowel) transplantations took place. Thus, these transplantations make the patient more susceptible to this sarcoma. Therefore, it boosts the market growth.
- High Strategic Collaborations by Market Players
In recent times, there have been significant changes in market strategies, such as product developments, mergers, and acquisitions. For instance, in May 2019, The U.S. FDA granted breakthrough therapy designation to Celgene's pomalidomide (Pomalyst) for treating patients with HIV-positive Kaposi sarcoma who have received prior chemotherapy, along with patients with HIV-negative Kaposi sarcoma. This boosts the growth of the market.
Opportunities
- Rising Demand for HAART
Growing demand for antiretroviral therapies leads to patients' faster recovery. For individuals with Epidemic (AIDS-associated) Kaposi sarcoma, antiretroviral treatment for HIV or AIDS is usually used before other therapies for treating the tumor and reducing the symptoms. HAART is preferred as individual therapy or chemotherapy based on the disease's spread and the patient's symptoms. Thus, this treatment procedure is greatly boosting the growth of the market.
- Rising Healthcare Awareness
Health awareness amongst the population is rising, which results in the prediction that drugs boost market growth. The innovative launches in medications for treating squamous cell carcinoma are expected to prompt the market simultaneously. For instance, in September 2014, F. Hoffmann-La Roche Ltd. Came up with a new Global Access Program for HIV viral load testing in partnership with United Nations Program on HIV/AIDS (UNAIDS), the Clinton Health Access Initiative, the President's Emergency Plan for AIDS Relief, and the Global Fund. The program was totally focused on HIV viral load testing. This creates more opportunities in the market.
Restraints/Challenges
- Lack of Skilled Professionals
A lack of trained healthcare professionals who are unaware of the knowledge of the treatment methods for this disease could limit the growth of the global Kaposi's sarcoma treatment market over a forecast period.
- High Cost
The huge expenditure on treatment methods impede the market growth. For instance, as per the data published by Monash University Malaysia in January 2016, the prices of major drugs that are used for the treatment of Kaposi sarcoma, such as liposomal doxorubicin, liposomal daunorubicin, or paclitaxel along with HAART, are increasing considerably, making them unaffordable for middle- and lower-income group patients.
This global Kaposi's sarcoma treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global Kaposi's sarcoma treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Kaposi's Sarcoma Treatment Market Scope
The global Kaposi's sarcoma treatment market is segmented on the basis of type, treatment, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Epidemic (AIDS Associated) Kaposi Sarcoma
- Classic (Mediterranean) Kaposi Sarcoma
- Endemic (African) Kaposi Sarcoma
- Latrogenic (Transplant-Related) Kaposi Sarcoma)
Treatment
- HAART
- Radiation Therapy
- Surgery
- Cryosurgery
- Chemotherapy
- Biological Therapy
End-Users
- Hospitals
- Homecare
- Speciality Centres
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Kaposi's Sarcoma Treatment Market Regional Analysis/Insights
对全球卡波西肉瘤治疗市场进行了分析，并按类型、治疗、分销渠道和最终用户提供了市场规模洞察和趋势。
全球卡波西肉瘤治疗市场报告涵盖的主要国家 有：北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
由于北美卡波西肉瘤患者数量的增加，加上器官移植和免疫抑制剂的摄入量的增加，预计该地区将拥有最高的市场增长。
由于器官移植和此类疗法在亚太地区的普及率不断提高，亚太地区在市场上占据主导地位。例如，根据全球器官捐献和移植观察站的数据，2017 年全球共移植了 1,39,024 个器官，这一数字相当高，因此市场份额也随之增加。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外，在提供国家数据预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和全球卡波西肉瘤治疗市场份额分析
全球卡波西肉瘤治疗市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对全球卡波西肉瘤治疗市场的关注有关。
全球卡波西肉瘤治疗市场的主要参与者包括：
- 强生私人有限公司（美国）
- 雅培（美国）
- AbbVie Inc.（美国）
- Bausch Health Companies Inc.（加拿大）
- 太阳制药工业有限公司 (印度)
- Aurobindo Pharma（印度）
- 鲁冰花（印度）
- Hikma Pharmaceuticals PLC（英国）
- Amneal Pharmaceuticals LLC.（美国）
- 辉瑞公司 (美国)
- Mylan NV（美国）
- 百时美施贵宝公司 (美国)
- 拜耳公司（德国）
研究方法：全球卡波西肉瘤治疗市场
数据收集和基准年分析是使用具有大样本量的数据收集模块进行的。市场数据使用市场统计和连贯模型进行分析和估计。市场份额分析和关键趋势分析也是市场报告中的主要成功因素。如需了解更多信息，请请求分析师致电或下拉询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，涉及数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们很自豪能够为现有和新客户提供符合其目标的数据和分析。报告可以定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（Factbook）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
